RxDoctor Payments Data

Andrew Dugan

Acute Care · Fort Smith, ARNPI 1659838092

Payments from drug & device makers

$1,754in general payments, 2019–2025

Across 99 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$617
  • Abiomed$182
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$177
  • Kestra Medical Technology Services, Inc.$121
  • Medtronic$103
  • AstraZeneca$99
  • plus $456 from 11 others

What the payments were for

  • Food & beverage$1,754100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,754 in reported general payments places this provider in the 75th percentile of 321 acute care providers in Arkansas.

See all acute care providers in Arkansas

Medicare billing

Part B allowed, 2024
$46,860
Medicare patients
374
Services billed
645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban386$280,825
EntrestoSacubitril/Valsartan157$137,661
FarxigaDapagliflozin Propanediol34$25,188
Repatha SureclickEvolocumab36$23,919
XareltoRivaroxaban22$17,197
JardianceEmpagliflozin15$16,703
Ranolazine ErRanolazine131$8,021
Praluent PenAlirocumab13$6,013
Metoprolol Succinate510$4,822
Isosorbide Mononitrate ErIsosorbide Mononitrate471$4,733
Atorvastatin Calcium492$3,794
Ezetimibe131$2,124
Isosorbide Dinitrate59$1,976
Carvedilol264$1,436
Amlodipine Besylate388$1,294

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$42$280,825386 claims
NovartisEntresto$617$137,661157 claims
AstraZenecaFarxiga$99$25,18834 claims
Johnson & JohnsonXarelto$85$17,19722 claims
Boehringer IngelheimJardiance$56$16,70315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 321 acute care providers in Arkansas.

Other acute care in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →